It showed that the surviving hepatoma cells after SHS are capable of EMT, and further research showed that SHS activated the Erk1/2 signal pathway; inhibiting the Erk1/2 pathway could inhibit the proliferation of hepatoma cells. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.